Booz Allen Q2 Revenue & Profit Fall (BAH)

Booz Allen reported a sharp year-over-year drop in profitability alongside an 8.1% revenue decline for the quarter ending Sept. 30, 2025. The company’s business is concentrated with U.S. government customers — defense accounted for roughly 49% of FY2025 revenue — and a large share of work is performed on cost-reimbursable contracts (60% in Q1 FY2026). That contract mix can make near-term results sensitive to estimate revisions and contract performance adjustments noted in the company’s filings. Investors should note structural operational features that provide context for the results: Booz Allen operates primarily as a prime contractor (95% prime, 5% subcontractor in Q2 FY2026) and carries $11.0 billion in remaining performance obligations, about 70% of which is scheduled for the next 24 months. These backlogs support near-term revenue visibility but do not eliminate execution risk from recompetes, contract estimate adjustments, or government procurement changes. The company also reported $130 million of interest paid in the first nine months of FY2026, a useful indicator of financing expense in the trailing period.

Key risk factors highlighted in public filings remain directly relevant after this quarter’s results: potential government audits and investigations (including labor and cost reporting), the absence of guaranteed work under multiple-award IDIQs/GWACs, and sensitivity to U.S. government budget decisions. The filings also emphasize operational risks tied to contract estimate adjustments (EAC process) and cybersecurity considerations given classified work. On the strategic side, Booz Allen continues to position technology — notably AI, cyber, and quantum-related capabilities — at the center of its go-forward plan. Historically the company has pursued organic investment and bolt-on acquisitions (for example, recent acquisitions to bolster mission and communications capabilities) while returning capital to shareholders ($1.2 billion in FY2025 through dividends and repurchases). For investors, monitoring win rates on recompetes, execution on technology-led contracts, and any changes in contract mix (cost-reimbursable vs. fixed-price) will be important to assess recovery in margins and top-line growth.